ARS Pharmaceuticals’ neffy® (epinephrine nasal spray) 1 mg is Now Available in the United States for Type I Allergic Reactions, including Anaphylaxis, in Pediatric Patients Weighing 15 to < 30 Kilograms

"The expanded availability of neffy represents real progress for our community, especially for young children who may be more likely to speak up about symptoms of a serious allergic reaction when they know epinephrine can be given without a needle," said Sung Poblete, PhD, RN, CEO of FARE (Food Allergy Research & Education), the leading nonprofit organization dedicated to food allergy. "This news means more families will have options that help them be ready to act and administer 'Epi first, Epi fast' when a ...